RXRX
Recursion Pharmaceuticals Inc
3.80$
+8.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +99.5% | +193.0% | +296.8% | +10.6% | +34.1% | +26.9% | |
| – | +38.2% | -85.6% | +430.3% | -11.8% | +6.2% | +167.4% | |
| – | – | +193.0% | -185.9% | – | +955.2% | -440.2% | |
| – | +38.2% | +113.6% | +15.1% | +54.9% | +30.3% | +35.3% | |
| – | +33.3% | +128.4% | +41.5% | +35.8% | +60.8% | -0.9% | |
| – | +37.2% | +119.0% | +23.0% | +48.2% | +40.2% | +22.2% | |
| – | – | – | – | – | – | – | |
| – | +114.2% | +117.1% | -98.1% | +76.4% | +1,520.6% | +15.1% | |
| – | – | – | – | – | – | – | |
| – | +35.6% | -1,059.5% | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.